Envoy Medical Inc./$COCH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Ticker
$COCH
Sector
Primary listing
Employees
45
Headquarters
Website
COCH Metrics
BasicAdvanced
$50m
-
-$0.80
1.90
-
Price and volume
Market cap
$50m
Beta
1.9
52-week high
$1.89
52-week low
$0.36
Average daily volume
121k
Financial strength
Current ratio
2.267
Quick ratio
2.072
Long term debt to equity
6.738
Total debt to equity
8.425
Interest coverage (TTM)
-20.94%
Profitability
EBITDA (TTM)
-22.618
Gross margin (TTM)
-229.49%
Net profit margin (TTM)
-9,875.64%
Operating margin (TTM)
-9,800.00%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-71.29%
Return on equity (TTM)
338.05%
Valuation
Price to revenue (TTM)
98.347
Price to book
4.77
Price to tangible book (TTM)
4.77
Price to free cash flow (TTM)
-1.079
Free cash flow yield (TTM)
-92.64%
Free cash flow per share (TTM)
-0.606
Growth
Revenue change (TTM)
10.38%
Earnings per share change (TTM)
-41.38%
3-year revenue growth (CAGR)
3.02%
3-year earnings per share growth (CAGR)
60.74%
COCH News
AllArticlesVideos
Envoy Medical to Present at Investor Conferences on June 25th
Newsfile Corp·4 hours ago
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th
Newsfile Corp·2 weeks ago
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
Newsfile Corp·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs